Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
41.03
+1.62 (4.11%)
At close: Jan 20, 2026, 4:00 PM EST
41.02
-0.01 (-0.02%)
After-hours: Jan 20, 2026, 4:54 PM EST
KNSA Market Cap
KNSA has a market cap or net worth of $3.11 billion as of January 20, 2026. Its market cap has increased by 117.76% in one year.
Market Cap
3.11B
Enterprise Value
2.77B
1-Year Change
117.76%
Ranking
Category
Stock Price
$41.03
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $3.11B, an increase of 229.74%. That is a compound annual growth rate of 16.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 2.99B | -4.46% |
| Dec 31, 2025 | 3.13B | 118.93% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.45% |
| Dec 30, 2022 | 1.04B | 28.46% |
| Dec 31, 2021 | 810.82M | -32.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |